Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
-
Published:2022-11-17
Issue:1
Volume:8
Page:
-
ISSN:2754-6993
-
Container-title:Schizophrenia
-
language:en
-
Short-container-title:Schizophr
Author:
Solanes AleixORCID, Mezquida Gisela, Janssen Joost, Amoretti SilviaORCID, Lobo AntonioORCID, González-Pinto Ana, Arango CelsoORCID, Vieta Eduard, Castro-Fornieles JosefinaORCID, Bergé Daniel, Albacete Auria, Giné EloiORCID, Parellada Mara, Bernardo MiguelORCID, Bioque Miquel, Morén Constanza, Pina-Camacho Laura, Díaz-Caneja Covadonga M., Zorrilla Iñaki, Corres Edurne Garcia, De-la-Camara Concepción, Barcones Fe, Escarti María José, Aguilar Eduardo Jesus, Legido Teresa, Martin Marta, Verdolini Norma, Martinez-Aran Anabel, Baeza Immaculada, de la Serna Elena, Contreras Fernando, Bobes Julio, García-Portilla María Paz, Sanchez-Pastor Luis, Rodriguez-Jimenez Roberto, Usall Judith, Butjosa Anna, Salgado-Pineda Pilar, Salvador Raymond, Pomarol-Clotet Edith, Radua Joaquim,
Abstract
AbstractDetecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. DeLisi, L. E. et al. Cerebral ventricular enlargement as a possible genetic marker for schizophrenia. Psychopharmacol. Bull. 21, 365–367 (1985). 2. Radua, J. & Carvalho, A. F. Route map for machine learning in psychiatry: absence of bias, reproducibility, and utility. Eur. Neuropsychopharmacol. 50, 115–117 (2021). 3. Rosen, M. et al. Towards clinical application of prediction models for transition to psychosis: a systematic review and external validation study in the PRONIA sample. Neurosci. Biobehav. Rev. 125, 478–492 (2021). 4. Smieskova, R. et al. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 34, 1207–1222 (2010). 5. Schmidt, A. et al. Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation. Schizophrenia Bull. 43, 375–388 (2017).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|